Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Adil Daud Alexander M. M. Eggermont Axel Hauschild Jens Gille Caroline Robert Ulrich Keilholz Dirk Schadendorf |
| Publication date | April 6, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |